Drugs / Structolipid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02321202 Comparator | Mar 2010 → Sep 2013 | cirrhosis of liver, liver cancer | Huazhong University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Structolipid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321202 ↗ |
| Modality | Other / unclassified | “We compared isonitrogenous total parenteral nutrition with 20% Structolipid and 10% n-3 fatty acid (Omegaven, Fresenius-Kabi, Germany) (treatment group) to Structolipid alone...” PMID 27614675 ↗ Aug 2016 |
| Route | Other | “total parenteral nutrition” PMID 27614675 ↗ Aug 2016 |